Skip to main content
Signal8

ARBEL IRIT

SEC insider (Form 3/4/5 filer). CIK 0001245607. Director at BRAINSTORM CELL THERAPEUTICS INC. (BCLI). 2 reported Form 4/5 transactions since Sep 2024; latest on Feb 26, 2026. Located in NEW YORK, NY.

Companies ARBEL IRIT has filed insider reports for

  • BRAINSTORM CELL THERAPEUTICS INC. (BCLI): Director
ARBEL IRIT profile photo

ARBEL IRIT

CIK: 0001245607

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BRAINSTORM CELL THERAPEUTICS INC. logo
BCLI

BRAINSTORM CELL THERAPEUTICS INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • BRAINSTORM CELL THERAPEUTICS INC. logo
    BCLI

    BRAINSTORM CELL THERAPEUTICS INC.

    Feb 26, 2026
    Award
    Direct
    120K shares-
  • BRAINSTORM CELL THERAPEUTICS INC. logo
    BCLI

    BRAINSTORM CELL THERAPEUTICS INC.

    Jan 1, 2025
    Award
    Direct
    30.7K shares-

1-2 of 2